SynthesisFrontiers in neuroinformatics2024
Artificial intelligence role in advancement of human brain connectome studies.
Synthesis in Frontiers in neuroinformatics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Emerging paradigms in connectome-guided neurosurgery for central nervous system tumors: a narrative review of structural and functional connectomics.Annals of medicine and surgery (2012) · 2026Review
- Artificial intelligence in neurodegenerative diseases research: a bibliometric analysis since 2000.Frontiers in neurology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neurons are interactive cells that connect via ions to develop electromagnetic fields in the brain. This structure functions directly in the brain. Connectome is the data obtained from neuronal connections. Since neural circuits change in the brain in various diseases, studying connectome sheds light on the clinical changes in special diseases. The ability to explore this data and its relation to the disorders leads us to find new therapeutic methods. Artificial intelligence (AI) is a collection of powerful algorithms used for finding the relationship between input data and the outcome. AI is used for extraction of valuable features from connectome data and in turn uses them for development of prognostic and diagnostic models in neurological diseases. Studying the changes of brain circuits in neurodegenerative diseases and behavioral disorders makes it possible to provide early diagnosis and development of efficient treatment strategies. Considering the difficulties in studying brain diseases, the use of connectome data is one of the beneficial methods for improvement of knowledge of this organ. In the present study, we provide a systematic review on the studies published using connectome data and AI for studying various diseases and we focus on the strength and weaknesses of studies aiming to provide a viewpoint for the future studies. Throughout, AI is very useful for development of diagnostic and prognostic tools using neuroimaging data, while bias in data collection and decay in addition to using small datasets restricts applications of AI-based tools using connectome data which should be covered in the future studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.